March 26, 2020 by Chain Drug Review
Alex Azar, COVID-19, NACDS, NACDS president and chief executive officer Steven Anderson
Leading Headlines, Pharmacy
WASHINGTON — NACDS this week praised recommendations by the Trump Administration to state governors on how to empower healthcare professionals to meet Americans’ needs amid COVID-19. NACDS urged the Administration and the states to remove more barriers to assure pharmacies and pharmacists are fully ready for the escalating demands of the pandemic. In a letter to the
March 25, 2020 by Chain Drug Review
COVID-19, NACDS, Steven Anderson
Leading Headlines, Pharmacy
WASHINGTON – The National Association of Chain Drug Stores (NACDS) has aligned with 110 other organizations in urging national, state and local leaders to help maintain the supply of critical products while confronting COVID-19. In a letter to policymakers released today, the groups urge a uniform definition of “critical infrastructure” at all levels of government – a
March 24, 2020 by Chain Drug Review
2019 Novel Coronavirus (COVID-19), NACDS, Steven Anderson
Leading Headlines, Pharmacy
WASHINGTON – The nation’s governors received from the National Association of Chain Drug Stores (NACDS) on Tuesday a recommendation of how to help maintain patients’ medication access during the COVID-19 pandemic. NACDS provided a model executive order that would foster medication access. The Association also noted the importance of recent action by Florida Gov. Ron DeSantis (R)
March 18, 2020 by Chain Drug Review
COVID-19, NACDS, Steven Anderson
Leading Headlines, Pharmacy
WASHINGTON – Governors, state legislators and state associations representing pharmacies and pharmacists have received recommendations from the National Association of Chain Drug Stores (NACDS) on ways to help assure patients receive the care they need during the COVID-19 pandemic. NACDS president and chief executive officer Steven Anderson, explained, “These recommendations focus on enhancing patients’ access to pharmacy healthcare
March 17, 2020 by Chain Drug Review
Immediate federal policymaking would empower pharmacies and pharmacists to help enhance the nation’s COVID-19 r, NACDS, Steven Anderson
Leading Headlines, Pharmacy
WASHINGTON – Immediate federal policymaking would empower pharmacies and pharmacists to help enhance the nation’s COVID-19 response right now, and as vaccines and other resources are developed and deployed. That was the message sent in a letter to the U.S. Congressional leadership and to the Administration by National Association of Chain Drug Stores (NACDS) president
March 13, 2020 by Chain Drug Review
Florida Pharmacy Association, Florida Retail Federation, Gov. Ron DeSantis, House Bill 389, NACDS, Steven Anderson
Leading Headlines, Pharmacy
TALLAHASSEE, Fla. – With the enactment of a new law – House Bill 389 – Florida has undertaken important public health efforts to enhance the convenience and accessibility of testing for common infectious diseases and appropriate treatment, the National Association of Chain Drug Stores (NACDS) said Friday. As a forward-leaning effort to help ensure the
March 13, 2020 by Chain Drug Review
NACDS, NACDS RxIMPACT Day on Capitol Hi
Leading Headlines, Pharmacy
(Editor’s note: The NACDS has issued an action alert following the decision to forego this year’s NACDS RxIMPACT Day on Capitol Hill.) ARLINGTON, Va. — Late-breaking changes in Congress’ operational response to COVID-19 made it appropriate to cancel the 12th Annual NACDS RxIMPACT Day on Capitol Hill that was planned for March 10-11. Over 400
March 11, 2020 by Chain Drug Review
House Bill 42, NACDS, New Mexico has taken a significant step toward improving health care access for its citizens, Steven Anderson
Leading Headlines, Pharmacy
WASHINGTON – With the enactment of a new law – House Bill 42 – New Mexico has taken a significant step toward improving health care access for its citizens, including those in rural areas and other underserved communities, the National Association of Chain Drug Stores (NACDS) said today. NACDS also hailed a unified effort of
March 9, 2020 by Chain Drug Review
2020 RxIMAPCT Day on Capitol Hill, NACDS, RxImpact Day, Steven Anderson
Leading Headlines, Pharmacy
NACDS has issued the following memo from Steven Anderson, president and CEO of NACDS, regarding the cancellation of 2020 RxIMAPCT Day on Capitol Hill that was scheduled for March 10th and 11th: Due to developments this morning, actual and potential changes in Congress’ response to COVID-19 make it appropriate to cancel the 2020 NACDS RxIMPACT
March 3, 2020 by Chain Drug Review
2020 Cost of Dispensing Study, NACDS, NASP, NCPA
Leading Headlines, Pharmacy
WASHINGTON – Pharmacy reimbursement paid by state Medicaid programs requires a fresh look and modernization, according to a new Cost of Dispensing Study commissioned by the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA) and the National Association of Specialty Pharmacy (NASP). DOWNLOAD STUDY DOWNLOAD Q&A In
March 2, 2020 by Chain Drug Review
Employee Retirement Income Security Act (ERISA), NACDS, National Association of Chain Drug Stores (NACDS) urges the U.S. Supreme Court to stand by its precedents and uphold an Arkansas law that “prevents [pharmacy benefit managers] PBM, U.S. Supreme Court, U.S. Supreme Court will consider is Rutledge v. Pharmaceutical Care Management Association
Featured Articles, Leading Headlines, Pharmacy
WASHINGTON – An amicus brief by the National Association of Chain Drug Stores (NACDS) urges the U.S. Supreme Court to stand by its precedents and uphold an Arkansas law that “prevents [pharmacy benefit managers] PBM contracts from reimbursing pharmacies at low rates that do not cover the costs of purchasing and dispensing expensive prescription medications,
February 27, 2020 by Chain Drug Review
Centers for Disease Control and Prevention’s (CDC) Division for Heart Disease and Stroke Prevention, NACDS, tional Hypertension Control Roundtable
Leading Headlines, Pharmacy
ARLINGTON, Va. — NACDS has announced that it will serve as a founding member of the National Hypertension Control Roundtable, which seeks marked health improvements by 2025. The National Hypertension Control Roundtable, launched by the Centers for Disease Control and Prevention’s (CDC) Division for Heart Disease and Stroke Prevention, will operate as a vibrant public,
February 26, 2020 by Steven Anderson
Morning Consult, NACDS, Steven Anderson
Opinion
(Editor’s note: The following article written by Steven Anderson, president and CEO, National Association of Chain Drug Stores appeared on Morning Consult’s website February 26th.) A simple truth is emerging about the complex topic known as pharmacy direct and indirect remuneration fees: They are as damaging to patients and to pharmacies as advertised. Adam J. Fein,
February 17, 2020 by David Pinto
CVS, NACDS, Publix, Rite Aid, Walgreens
February 17, 2020, Opinion
As The New York Times has been doing of late with astonishing regularity and surprising frequency, the newspaper of record has at last gotten round to demolishing the retail pharmacy business. In a front-page story on February 1, the Times shrieked, in its headline, that “Overloaded Pharmacists Warn They’re Making Fatal Mistakes.” The story proceeded